Brief: Vivos, Inc. Completes Common Stock Equity Financing To Fund Roll Out Of Isopet And Eliminate Toxic Debt
10/10/2018 12:38
Oct 10 (Reuters) - Vivos Inc RDGL.PK :
* VIVOS, INC. COMPLETES COMMON STOCK EQUITY FINANCING TO
FUND ROLL
OUT OF ISOPET AND ELIMINATE TOXIC DEBT
Source text for Eikon: ID:nGNX827N3r
Further company coverage: RDGL.PK
((Briefs@thomsonreuters.com;))
Recent news on Vivos
See all newsBrief: Vivos Inc. Announces Progress Toward FDA Investigational Device Exemption (Ide) Submission
Brief: Vivos Inc. Strengthens Strategic Collaboration With Exubrion Therapeutics
Brief: Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., To Support Ide Submission For Radiogel®
Brief: Vivos Board Authorizes To Establish A Corporate Entity In India
Brief: Vivos Inc. Achieves Record Growth In IsoPet® Animal Cancer Treatments In Q1 2025